AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹5,526 Cr | ₹3,925 Cr | ₹2,435 Cr | ₹2,387 Cr | ₹5,016 Cr |
What is the latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹5,526 Cr |
| Mar2025 | ₹3,925 Cr |
| Mar2024 | ₹2,435 Cr |
| Mar2023 | ₹2,387 Cr |
| Mar2022 | ₹5,016 Cr |
How is Cash Flow from Operating Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,526 Cr | 40.81 | |
| Mar2025 | ₹3,925 Cr | 61.21 | |
| Mar2024 | ₹2,435 Cr | 2.00 | |
| Mar2023 | ₹2,387 Cr | -52.42 | |
| Mar2022 | ₹5,016 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹98,968.8 Cr | -0.9% | 7.3% | 52.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.9% |
7.3% |
52.9% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses